A novel liver cancer therapy targeting tumour stroma

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1113842

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

In Australia, there are 1,300 new cases of liver cancer each year with an average survival of 7 months. Liver cancer is now the most rapidly increasing cancer, probably caused by more hepatitis, obesity and diabetes. Our commercial partner has a novel innovative new antibody that shrinks other cancer types and we want to see how well it combats liver cancer in mice. This antibody has a raft of superior features and we have a clear plan towards making it available to patients.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2018

Funding Scheme: Development Grants

Funding Amount: $387,902.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Chemotherapy

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antibody cancer therapy | fibroblasts | liver cancer | protease inhibitors | stromal cells

Related Links